Ysios: Sanifit takeout is a ‘before and after’ moment in Spain

Sanifit, the best-funded venture-backed therapeutics developer in Spain’s history, has now been acquired in the biggest takeout yet for a pure-play Spanish biotech.

Vifor Pharma Ltd. (SIX:VIFN) said Monday it would acquire Sanifit Therapeutics S.A. for €205 million ($230.9 million) up front, adding a late-stage cardio-renal asset for calcification disorders to its broad kidney disease portfolio. Vifor also paid CHF20 million up front for another private biotech with calcification programs, Switzerland-based Inositec AG...